Literature DB >> 12505351

Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance.

John O Miners1, Ross A McKinnon, Peter I Mackenzie.   

Abstract

UDP-Glucuronosyltransferase (UGT), the microsomal enzyme responsible for glucuronidation reactions, exists as a superfamily of enzymes. Genetic polymorphism has been described for 6 of the 16 functional human UGT genes characterised to date, namely UGT 1A1, 1A6, 1A7, 2B4, 2B7 and 2B15. Since glucuronidation is an essential pathway for the elimination of a myriad of xenobiotics and endogenous compounds, genetic polymorphism of UGT is potentially of toxicological and physiological importance. However, functional significance has only been convincingly demonstrated for genetic polymorphism of UGT1A1. Apart from impaired bilirubin glucuronidation, the mutations responsible for Gilbert syndrome also affect the elimination of a limited number of xenobiotics. It has been proposed on the basis of altered catalytic activity of mutants of UGT 1A6, 1A7 and 2B15 that genetic polymorphism of these forms may be of toxicological significance, but this is yet to be proven.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12505351     DOI: 10.1016/s0300-483x(02)00449-3

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  42 in total

1.  Comparison of intestinal absorption and disposition of structurally similar bioactive flavones in Radix Scutellariae.

Authors:  Chenrui Li; Li Zhang; Limin Zhou; Siu Kwan Wo; Ge Lin; Zhong Zuo
Journal:  AAPS J       Date:  2011-12-14       Impact factor: 4.009

2.  An in vitro approach to estimate putative inhibition of buprenorphine and norbuprenorphine glucuronidation.

Authors:  Stephanie Oechsler; Gisela Skopp
Journal:  Int J Legal Med       Date:  2010-01-29       Impact factor: 2.686

Review 3.  Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors:  Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  Metabolic activation and analgesic effect of flupirtine in healthy subjects, influence of the polymorphic NAT2, UGT1A1 and GSTP1.

Authors:  Werner Siegmund; Christiane Modess; Eberhard Scheuch; Karen Methling; Markus Keiser; Ali Nassif; Dieter Rosskopf; Patrick J Bednarski; Jürgen Borlak; Bernd Terhaag
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

5.  Adjustment of the area under the concentration curve by terminal rate constant for bioequivalence assessment in a parallel-group study of lamotrigine.

Authors:  Jiansong Yang; Peiming Ma; Jonathan Bullman; Andrew Nicholls; Chao Chen
Journal:  Br J Clin Pharmacol       Date:  2019-01-17       Impact factor: 4.335

6.  Enzymatic analysis of glucuronidation of synthetic cannabinoid 1-naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FDU-PB-22).

Authors:  Sabrina Jones; Azure L Yarbrough; Amal Shoeib; John M Bush; William E Fantegrossi; Paul L Prather; Anna Radominska-Pandya; Ryoichi Fujiwara
Journal:  Xenobiotica       Date:  2019-03-20       Impact factor: 1.908

7.  Prognostic value of chemotherapy-induced hematological toxicity in metastatic colorectal cancer patients.

Authors:  Laurie Rambach; Aurelie Bertaut; Julie Vincent; Veronique Lorgis; Sylvain Ladoire; Francois Ghiringhelli
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

8.  Citrus fruit intake is associated with lower serum bilirubin concentration among women with the UGT1A1*28 polymorphism.

Authors:  Misty R Saracino; Jeannette Bigler; Yvonne Schwarz; Jyh-Lurn Chang; Shiuying Li; Lin Li; Emily White; John D Potter; Johanna W Lampe
Journal:  J Nutr       Date:  2009-01-13       Impact factor: 4.798

Review 9.  The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

Authors:  G Neil Thomas; Paul Chan; Brian Tomlinson
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

10.  Abacavir and metabolite pharmacokinetics in HIV-1-infected children and adolescents.

Authors:  Shane J Cross; John H Rodman; Jane C Lindsey; Brian L Robbins; Charles H Rose; Geoffrey J Yuen; Lawrence J D'angelo
Journal:  J Acquir Immune Defic Syndr       Date:  2009-05-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.